280MO Progression free survival with endocrine therapy,...

280MO Progression free survival with endocrine therapy, before or after chemotherapy, in patients with hormone receptor-positive/HER2-negative metastatic breast cancer in a large multicenter national observational study

Corbaux, P., Lardy-Cleaud, A., Alexandre, M., Fontanilles, M., Levy, C., Viansone, A.A., Mailliez, A., Debled, M., Gonçalves, A., Le Du, F., Lerebours, F., Ferrero, J-M., Eymard, J-C., Mouret-Reynier
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.382
Date:
September, 2020
File:
PDF, 87 KB
2020
Conversion to is in progress
Conversion to is failed